Novartis 15 may 2026 Novartis, amid reorg, cuts ‘select number’ of biomedical research roles - Fierce Biotech
Novartis 12 may 2026 New prostate cancer hopes from Roche and Novartis | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Novartis 12 may 2026 Biotech and the Efficiency Revolution: Why the Final Mile Matters Most for Novartis, BioNTech, and BioNxt - news.financial
Novartis 7 may 2026 Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis - Fierce Biotech
Novartis 5 may 2026 Biopharma bites: FDA withholds vaccine data, plus staffing cuts for Novartis, Gilead - FirstWord Pharma
Novartis 4 may 2026 After March cuts, Novartis trims another 60 roles at US headquarters - Fierce Pharma
Novartis 4 may 2026 Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study - Fierce Biotech
Novartis 4 may 2026 Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville - Wake County Government (.gov)
Novartis 30 abr 2026 Novartis to build Morrisville pharma facility as part of $23 billion push - CBS 17
Novartis 30 abr 2026 Novartis rounds out $23B US investment push with plans for North Carolina API plant - Fierce Pharma
Novartis 30 abr 2026 Novartis Reshapes Growth With Biotech Deals And AI Powered R&D Push - Yahoo Finance
Novartis 29 abr 2026 Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval - BioSpace